CBIZ Investment Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.22K Sell
12
-92
-88% -$32.8K ﹤0.01% 244
2025
Q4
$34K Buy
104
+25
+32% +$7.93K ﹤0.01% 189
2025
Q3
$22.3K Buy
79
+30
+61% +$8.7K ﹤0.01% 237
2025
Q2
$13.7K Sell
49
-43
-47% -$12.2K ﹤0.01% 307
2025
Q1
$28.7K Buy
92
+85
+1,214% +$25.1K ﹤0.01% 173
2024
Q4
$1.82K Buy
+7
New +$2.08K ﹤0.01% 401
2020
Q1
Hold
0
165

Other funds holding AMGN

CBIZ Investment Advisory Services's AMGN Position: Q1 2026 in Review

CBIZ Investment Advisory Services reduced its Amgen (AMGN) stake by 88% in Q1 2026, selling an estimated $32.8K and leaving 12 shares worth $4.22K. The position accounts for ﹤0.01% of the portfolio, ranked #244.

CBIZ Investment Advisory Services first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $34K in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • CBIZ Investment Advisory Services held 12 shares of Amgen worth $4.22K as of Q1 2026.
  • CBIZ Investment Advisory Services sold 92 Amgen shares in Q1 2026, an estimated $32.8K.
  • Amgen made up ﹤0.01% of CBIZ Investment Advisory Services's portfolio in Q1 2026, its #244 holding.
  • CBIZ Investment Advisory Services first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • CBIZ Investment Advisory Services's Amgen position peaked at $34K in Q4 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.